Affiliation:
1. Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM)
2. Facultad de Ingeniería, Universidad Nacional Autónoma de México (UNAM)
3. IIMAS, Universidad Nacional Autónoma de México (UNAM)
4. UMDI, Universidad Nacional Autónoma de México (UNAM)
5. Asociación Para Evitar la Ceguera
6. INDEREB
7. Instituto Mexicano de Oftalmología (IMO), I.A.P
Abstract
Abstract
Given the ever-increasing prevalence of type 2 diabetes and obesity, the pressure on global healthcare is expected to be colossal, especially in terms of blindness. Electroretinogram (ERG) has long been perceived as a first-use technique for diagnosing eye diseases, and some studies suggested its use for preventable risk factors of type 2 diabetes and thereby diabetic retinopathy (DR). Here, we show that in a non-evoked mode, ERG signals contain spontaneous oscillations that predict disease cases in rodent models of obesity and in people with overweight, obesity, and metabolic syndrome but not yet diabetes, using one single random forest-based model. Classification performance was both internally and externally validated, and correlation analysis showed that the spontaneous oscillations of the non-evoked ERG are altered before oscillatory potentials, which are the current gold-standard for early DR. Principal component and discriminant analysis suggested that the slow frequency (0.4–0.7 Hz) components are the main discriminators for our predictive model. In addition, we established that the optimal conditions to record these informative signals, are 5-minute duration recordings under daylight conditions, using any ERG sensors, including ones working with portative, non-mydriatic devices. Our study provides an early warning system with promising applications for prevention, monitoring and even the development of new therapies against type 2 diabetes.
Publisher
Research Square Platform LLC
Reference103 articles.
1. Stem MS, Gardner TW, Comer GM. 42: Management of Diabetic Retinopathy. ADA. Therapy for Diabetes Mellitus and Related Disorders. ADA. 2014.
2. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities;Das T;Eye,2021
3. Cost of a group translation of the diabetes prevention program: Healthy living partnerships to prevent diabetes;Lawlor MS;American Journal of Preventive Medicine,2013
4. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study;Liu J;Circulation: Cardiovascular Quality and Outcomes,2020
5. Kaur G, Lakshmi PVM, Rastogi A, Bhansali A, Jain S, Teerawattananon Y, et al. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis. Atkin SL, editor. PLOS ONE. 2020;15: e0242415. doi:10.1371/journal.pone.0242415